These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38587248)

  • 21. [Pharmacy clinics. How I treat... A patient with hypertriglyceridemia].
    Scheen AJ
    Rev Med Liege; 1995 Jun; 50(6):237-8. PubMed ID: 7617998
    [No Abstract]   [Full Text] [Related]  

  • 22. [Introduction to drug therapy].
    Ishii H; Yoshida M
    Nihon Rinsho; 2013 Sep; 71(9):1636-40. PubMed ID: 24205727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipid therapy. Prevention of arteriosclerotic cardiovascular diseases].
    Windler E
    Internist (Berl); 2001 Jan; 42(1):92-110. PubMed ID: 11271625
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
    Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
    [No Abstract]   [Full Text] [Related]  

  • 26. Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes.
    Alexopoulos AS; Qamar A; Hutchins K; Crowley MJ; Batch BC; Guyton JR
    Curr Diab Rep; 2019 Feb; 19(4):13. PubMed ID: 30806837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical decrease in serum high-density lipoprotein cholesterol with Tredaptive® (m/r nicotinic acid 1 g and laropiprant 20 mg).
    Sharpe P
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):584-5. PubMed ID: 21868415
    [No Abstract]   [Full Text] [Related]  

  • 28. Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
    Scherer DJ; Nicholls SJ
    Vasc Health Risk Manag; 2015; 11():203-9. PubMed ID: 25848301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination lipid therapy in type 2 diabetes.
    Saely CH; Rein P; Drexel H
    N Engl J Med; 2010 Aug; 363(7):692; author reply 694-5. PubMed ID: 20701533
    [No Abstract]   [Full Text] [Related]  

  • 30. [Elevated triglyceride level].
    Matikainen N
    Duodecim; 2009; 125(4):371-80. PubMed ID: 19358417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hypertriglyceridemia in the diabetic patient.
    Jialal I; Amess W; Kaur M
    Curr Diab Rep; 2010 Aug; 10(4):316-20. PubMed ID: 20532703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triglyceride-Rich Lipoproteins.
    Kockx M; Kritharides L
    Cardiol Clin; 2018 May; 36(2):265-275. PubMed ID: 29609756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia.
    Koh KK; Quon MJ; Shin KC; Lim S; Lee Y; Sakuma I; Lee K; Han SH; Shin EK
    Atherosclerosis; 2012 Feb; 220(2):537-44. PubMed ID: 22153696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of hypertriglyceridemia.
    Simha V
    BMJ; 2020 Oct; 371():m3109. PubMed ID: 33046451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia.
    Gouni-Berthold I
    Atheroscler Suppl; 2017 Nov; 30():19-27. PubMed ID: 29096837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
    Arbel Y; Klempfner R; Erez A; Goldenberg I; Benzekry S; Shlomo N; Fisman EZ; Tenenbaum A;
    Cardiovasc Diabetol; 2016 Jan; 15():11. PubMed ID: 26794137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of intravenous insulin, apheresis and oral lipid-lowering agents on non-fasting hypertriglyceridemia and associated pancreatitis.
    Frankova D; Olson KM; Whyms BJ; Guevara Hernandez MA; Franko J
    Postgrad Med; 2018 Jun; 130(5):494-500. PubMed ID: 29702000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safe and Effective Triglyceride-Lowering Therapy for Hypertriglyceridemia Associated Pancreatitis: Insulin Mono-therapy in a Non-Diabetic Patient.
    Xie C; Stevens DC; Sturm T
    S D Med; 2018 Jan; 71(1):26-28. PubMed ID: 29439301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertriglyceridemia: A review of the evidence.
    Elkins C; Friedrich D
    Nurse Pract; 2018 Oct; 43(10):22-29. PubMed ID: 30153192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hypertriglyceridaemia. Treatment with plasmapheresis.
    Izquierdo-Ortiz MJ; Abaigar-Luquin P
    Nefrologia; 2012 May; 32(3):417-8. PubMed ID: 22592440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.